NCT05163223 2024-06-17
Cornerstone001
Aston Sci. Inc.
Phase 2 Terminated
Clinical Trials
4 trialsNCT01403064 2021-05-11
Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
CSL Behring
Phase 2 Terminated
NCT00738699 2017-03-30
FAR-122
Morphotek
Phase 2 Terminated
NCT00850577 2015-10-12
Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Phase 2 Terminated